Subscribe: Market Wire - Medical and Healthcare: Medical Devices
http://img.marketwire.com/rss/mwMHMD.rss
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
announces  cancer  clinical  company  development  jul  july  marketwired jul  marketwired july  marketwired  medical  new  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Medical Devices

Marketwired - Medical Devices



Marketwired - Medical Devices



Last Build Date: Fri, 21 Jul 2017 09:31:32 EDT

Copyright: Copyright: (C) Marketwired
 



eWellness Signs LOI For Comprehensive PT Services with US Health Center and another US Healthcare Payer Group

Fri, 21 Jul 2017 09:00:00 EDT

CULVER CITY, CA--(Marketwired - Jul 21, 2017) - eWellness Healthcare Corporation -- (OTCQB: EWLL) -- a provider of the state of the art PHZIO Platform for the physical therapy and telehealth markets, announced today that it has signed a Letter of Intent Agreement between US Health Center, Inc. ("USHC") and an undisclosed US healthcare provider. Between both USHC and the undisclosed US healthcare payer group they anticipate having approximately 100,000 healthcare insured customers by the end of 2017. The Parties to this LOI have agreed to use their best efforts to conclude Definitive Agreements between the Parties over the next 90 days. According to eWellness, these new agreements (if executed) are anticipated to generate initially up to $4.2 million in annual reoccurring gross revenue for the Company. This level of sales is anticipated to allow the Company to gain cash flow positive operations during the latter part of 2017.




Titan Medical Inc. Announces Second Closing of Previously Announced Public Offering

Fri, 21 Jul 2017 08:43:32 EDT

TORONTO, ON--(Marketwired - July 21, 2017) -




Rand Capital Announces Second Quarter 2017 Financial Results Conference Call and Webcast

Thu, 20 Jul 2017 16:15:00 EDT

BUFFALO, NY--(Marketwired - July 20, 2017) - Rand Capital Corporation (NASDAQ: RAND) ("Rand"), a venture capital company which invests in growth businesses with unique product, service or technology concepts, announced today that it will release its second quarter 2017 financial results before the opening of financial markets on Monday, August 7, 2017.




ECPO Files Issuers Company Related Action Notification with the Financial Industry Regulatory Authority requesting Name and Symbol Change

Thu, 20 Jul 2017 13:19:52 EDT

The Company Also Updated Progress on the Validation Process for its ITV-1 Patented HIV/AIDS Treatment




Rand Capital Provides Follow-on Investment in GENICON, Medical Device Manufacturer

Thu, 20 Jul 2017 10:00:00 EDT

Rand is largest investor in $6.6 million capital raise and refinancing




DirectTrust Reports Steady Growth in Number of Direct Exchange Users, Addresses and Transactions during Second Quarter

Thu, 20 Jul 2017 09:30:00 EDT

Five new members join DirectTrust since April 1




MTBC Named in 2017 Ranking of the Top 15 Medical Billing Companies in the United States

Thu, 20 Jul 2017 09:15:08 EDT

SOMERSET, NJ--(Marketwired - Jul 20, 2017) - MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary, cloud-based healthcare IT solutions and services, today announced that it has been ranked as one of the top 15 medical billing companies in the United States, according to Becker's Hospital Review.




A Third Highly Successful Ultrasound Executive joins Ventripoint

Thu, 20 Jul 2017 09:14:48 EDT

TORONTO, ONTARIO--(Marketwired - July 20, 2017) - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company") (TSX VENTURE:VPT) is announcing the appointment of Desmond Hirson as Vice-President, Development and Operations.




SANUWAVE Appoints Alat Medika Indonesia as Distributor for dermaPACE and Liaison to Clinical Trials Participation for Company's Wound Care Product(s) in Indonesia

Thu, 20 Jul 2017 09:00:00 EDT

SUWANEE, GA--(Marketwired - Jul 20, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the Company has appointed Alat Medika Indonesia as distributor for dermaPACE® and liaison for clinical trials participation for Company's wound care product in Indonesia. The expected revenue from this agreement will be north of $1 million over the next three years.




Heating Up: Who Benefits from the Growth in Vaping? -- CFN Media

Thu, 20 Jul 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Jul 20, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article examining the growth of vaping as an alternative to smoking, and Nutritional High International Inc.'s (CSE: EAT) (OTC: SPLIF) FLI liquid concentrate product line. Smoking tobacco has been popular for thousands of years, but vaporizers are quickly replacing the habit with a healthier alternative -- especially in the cannabis industry. These vaporizers provide a cheaper and healthier alternative to smoking, while providing a smoother and more socially-acceptable experience.




Streetwise Reports Examines How Progress in Pain Control and Liver Disease Programs Spurs Rise in DURECT Corp.'s Rating

Thu, 20 Jul 2017 08:45:00 EDT

SAN FRANCISCO, CA--(Marketwired - July 20, 2017) - News about progress in two of this biotech's development programs prompted a rating upgrade by analyst Adam Walsh of Stifel Nicolaus & Company.




Propanc Biopharma Receives Acceptance of Key Patent Application for Cancer Treatment in China

Thu, 20 Jul 2017 08:30:00 EDT

Patent covers use of a pharmaceutical composition comprising trypsinogen and chymotrypsinogen




Lexington Biosciences Introduces Medical Advisory Board

Thu, 20 Jul 2017 08:30:00 EDT

Advisory team prepares to move HeartSentry through clinical studies




Increased Revenues, Refill Gains Identified by American Pharmacies as Top Benefits of RxCOMPASS, Powered by FDS Inc.'s myDataMart

Thu, 20 Jul 2017 08:30:00 EDT

Buying cooperative shares study results demonstrating financial gains generated by robust pharmacy business intelligence tool




Company Announces Continued Development of its Online Presence and Ongoing Negotiations for an Extraction Joint-Venture to Satisfy CBD Oil Demand in the Northeast

Thu, 20 Jul 2017 08:00:00 EDT

NEW YORK, NY--(Marketwired - Jul 20, 2017) - HempAmericana, Inc. (OTC PINK: HMPQ) is proud to announce it is now selling CBD oil off its newly designed website www.hempamericana.net. It is important for the company to continue its retail sales while it develops a hemp extraction process directly under its control. The company's CEO Salvador Rosillo stated, "We are extremely excited to have retail sales as a base, while we develop our own internal extraction process. While these early sales are financially nominal and the orders are small, we will implement a SEO program that will target markets to sell our oils into in the near future."




Clinical Teams From Top Pharma Companies Are Overcoming Challenges in Planning and Implementing Adaptive Trial Design Studies

Wed, 19 Jul 2017 19:23:00 EDT

RESEARCH TRIANGLE PARK, NC--(Marketwired - July 19, 2017) - A recent study of Top 10, Top 50, and small medical device companies found that addressing regulators' concerns for late-stage studies is the most common challenge clinical development teams encounter during their adaptive trial design preparations, according to research published by business intelligence firm Cutting Edge Information.




3D Signatures Inc. Announces Short Form Prospectus Offering to Raise Up to C$5 Million

Wed, 19 Jul 2017 12:34:54 EDT

TORONTO, ONTARIO--(Marketwired - July 19, 2017) -




ORHub, Inc. Executing Aggressive Expansion Strategy with Introduction of Third Service Line

Wed, 19 Jul 2017 11:54:40 EDT

NEWPORT BEACH, CA--(Marketwired - Jul 19, 2017) - Less than a week after declaring its nationwide deployment strategy, ORHub, Inc. (OTC: ORHB) today announces its entrance into the cardiac segment of health care through the launch of its Cardiac and Cardiology service line.




Growth of Social Isolation and Loneliness in Seniors Underscores Need for Technology Solutions

Wed, 19 Jul 2017 10:30:00 EDT

Whitepaper from GreatCall and Aging in Place Technology Watch discusses health risks associated with loneliness and offers solutions to mitigate risks




The Alliance for Regenerative Medicine Announces Presenting Companies at 2017 Cell & Gene Meeting on the Mesa

Wed, 19 Jul 2017 10:16:21 EDT

WASHINGTON, DC--(Marketwired - Jul 19, 2017) - The Alliance for Regenerative Medicine (ARM) today announced the initial slate of companies selected to present at its upcoming Cell & Gene Meeting on the Mesa annual conference, October 4-6, 2017.







UPDATE - Medovex Corporation Announces First Human Cases Using Its DenerveX Device and First Revenue Events

Wed, 19 Jul 2017 09:17:59 EDT

Highly Disruptive and Patented Less Invasive Device with Faster Recovery Time than Current Surgical Treatment Options for Facet Joint Syndrome




Mobile Games Provide Inroads to Cannabis Consumers -- CFN Media

Wed, 19 Jul 2017 09:13:30 EDT

SEATTLE, WA--(Marketwired - Jul 19, 2017) -  CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article taking a closer look at fully-reporting First Harvest Corp. (OTCQB: HVST) and how mobile games could help cannabis companies reach consumers in an otherwise off-limits advertising environment.







Invictus MD Completes First Harvest & Breaks Ground on Expansion -- CFN Media

Wed, 19 Jul 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Jul 19, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article examining Invictus MD Strategies Corp.'s (TSX VENTURE: IMH) (OTC PINK: IVITF) progress in building out its presence in Canada's licensed producer marketplace, as well as its successful ancillary businesses.




Streetwise Reports Examines How Biotech with Alzheimer's Focus Makes Progress on Several Fronts

Wed, 19 Jul 2017 08:45:00 EDT

SAN FRANCISCO, CA--(Marketwired - July 19, 2017) - In its corporate update for Q2/17, a Canada-based biotech targeting neurological disorders including Alzheimer's disease informed investors of advancements in several programs, including designation of a second validated lead compound in development.




BriaCell Provides Clinical Update on its Ongoing Phase I/IIa Clinical Study of BriaVax(TM) in Advanced Breast Cancer

Wed, 19 Jul 2017 08:30:00 EDT

BERKELEY, CA and VANCOUVER, BC--(Marketwired - July 19, 2017) - BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX VENTURE: BCT) (OTCQB: BCTXF), an immuno-oncology focused biotechnology company, provided a clinical update regarding its US-based open-label Phase I/IIa clinical trial evaluating the safety and efficacy of BriaVaxT, a genetically engineered whole-cell vaccine derived from a human breast cancer cell line, to treat advanced breast cancer.




CFN Media Exclusive Interview with OWCP's Dr. Sharon Rozenblat

Wed, 19 Jul 2017 08:30:00 EDT

SEATTLE, WA--(Marketwired - Jul 19, 2017) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article and exclusive interview with Dr. Sharon Rozenblat, Advisory Board Member for OWC Pharmaceutical Research Corp. (OTCQB: OWCP). Dr. Rozenblat is largely responsible for the development of the company's active cannabinoid topical skin cream, and the interview focuses on that product and its potential in the rapidly growing multi-billion dollar psoriasis market.




Ten Healthcare Organizations Select BIO-key Fingerprint Biometric Authentication to Meet Multifactor Authentication Requirements

Wed, 19 Jul 2017 08:03:00 EDT

Organizations find fingerprint authentication faster, more convenient and more secure than alternatives such as passwords




Medovex Announces First Human Cases Using Its DenerveX Device and First Revenue Events

Wed, 19 Jul 2017 08:00:00 EDT

Highly Disruptive and Patented Less Invasive Device with Faster Recovery Time than Current Surgical Treatment Options for Facet Joint Syndrome




Emerging Issues for Pharma R&D: A Practical Approach for Pediatric Drug Programs, New Webinar Hosted by Xtalks

Wed, 19 Jul 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - July 19, 2017) - In this webinar scheduled for Wednesday, August 16, 2017 at 11am EDT (4pm BST/), industry experts Dr. Barry Mangum from Paidion Research and Dr. JF Marier from Certara will discuss how pediatric considerations fit into the overall drug development program. They will also make recommendations for addressing issues from both a practical and scientific perspective. Anonymized case studies will be presented with a review of historical issues with a focus on solutions for today (i.e. licensed comparators differences in US and EU, importation issues, and endpoint selection




Medigus Expands Global Commercial Availability of MUSE Through Distribution Agreement With Izasa Hospital, S.L.U. in Spain

Wed, 19 Jul 2017 07:00:00 EDT

OMER, ISRAEL--(Marketwired - Jul 19, 2017) -  Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced a distribution agreement in Spain with Izasa Hospital, S.L.U., a distributor of medical products in the hospital sector. The five year commercialization agreement took effect July 1, 2017; Izasa Hospital, S.L.U. will be required to purchase a minimum of EUR 1.4 million of Medigus Ultrasonic Surgical Endostapler (MUSET) equipment over the course of the agreement.




PathPartner Technology Contributes to Arthromeda's Successful Preclinical Study of Arthrosight-PS(TM) Hip Alignment Navigation System

Wed, 19 Jul 2017 03:01:00 EDT

FREMONT, CA--(Marketwired - July 19, 2017) - PathPartner Technology Inc., a technology enabler in developing intelligent systems, announces a successful cadaveric study of Arthromeda's (www.arthromeda.com) innovative patient-specific hip alignment navigation product, Arthrosight-PST.




Zecotek Announces Non-Brokered Private Placement

Tue, 18 Jul 2017 20:00:00 EDT

SINGAPORE--(Marketwired - July 18, 2017) -




ICTV Brands, Inc. Terminates Royalty Agreement

Tue, 18 Jul 2017 16:00:00 EDT

WAYNE, PA--(Marketwired - Jul 18, 2017) - ICTV Brands, Inc. (OTCQX: ICTV), (CSE: ITV)




Avantor Opens New Life Sciences Research Center

Tue, 18 Jul 2017 12:03:09 EDT

New Innovation Center in Bridgewater, New Jersey serves as a distinct center of collaboration where Avantor can provide broad contract research capabilities covering gene to protein expression, as well as final formulation and drug delivery




Medifirst Solutions Signs Professional Football Player Jordan Poyer as Spokesperson for the Time Machine Laser

Tue, 18 Jul 2017 10:10:46 EDT

FREEHOLD, NJ--(Marketwired - Jul 18, 2017) - MEDIFIRST SOLUTIONS, INC. (OTC PINK: MFST) (the "Company" or "Medifirst"), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device, is pleased to announce that it has signed NFL player Jordan Poyer as a spokesperson for the Time Machine Laser.




Propanc Biopharma Announces Joint Research Partnership with Jaen University, Spain

Tue, 18 Jul 2017 08:30:00 EDT

MELBOURNE, AUSTRALIA--(Marketwired - July 18, 2017) - Propanc Biopharma Inc. (OTCQB: PPCB) ("Propanc Biopharma" or "the Company"), a clinical stage biopharmaceutical company focusing on development of new and proprietary treatments for cancer patients suffering from solid tumors such as pancreatic, ovarian and colorectal cancers, today announced the establishment of a 4 year joint research partnership with the Jaén University, based in Andalucía, Spain. The primary objective of the partnership is to expand Propanc Biopharma's product pipeline, by discovering new compounds based on the mode of action of naturally derived proenzymes, trypsinogen and chymotrypsinogen, which are the key active ingredients in the Company's lead product, PRP.




Dewmar International BMC, Inc. (DEWM) Files Provisional Patent to Treat Lung Cancer with Cannabinoids

Tue, 18 Jul 2017 08:13:56 EDT

BATON ROUGE, LA--(Marketwired - Jul 18, 2017) -  Dewmar International BMC, Inc.  (OTC PINK: DEWM) announced today that it has filed a provisional patent with the United States Patent and Trademark Office for the treatment of lung cancer with cannabinoids. The title of the provisional patent filing is Cannabinoid Formulation to Treat Lung Cancer.




Cancer as a Chronic Disease: The Past, the Present and the Future of Cancer Research

Tue, 18 Jul 2017 08:00:00 EDT

This Xtalks webinar, conducted by one of the US's foremost cancer researchers, Dr. Lee Schwartzberg, of the West Cancer Centre and Scientific Leader at George Clinical, will discuss cancer as a chronic disease and how researching cancer under this new archetype is adjusting the way in which clinical oncology trials are conducted and how cancer patients are treated




Advanced Proteome Therapeutics Announces Collaboration to Develop Cancer Therapeutic

Tue, 18 Jul 2017 08:00:00 EDT

VANCOUVER, BC--(Marketwired - July 18, 2017) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) a biotechnology company focused on developing superior targeted protein therapeutics is pleased to announce a collaboration with the National Research Council of Canada (NRC). Through this arrangement both parties have forged a strategic relationship to further the development of antibody-drug conjugates (ADCs).




Into the Great Wide Open: PTC's transformation & Global Journey to Bring Patients a First Ever Rare Disease Therapy, New Webinar Hosted by Xtalks

Tue, 18 Jul 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - July 18, 2017) - The rare disease biopharmaceutical landscape continues to evolve, but despite the advances made, only five percent of an estimated 7,000 rare diseases have an available treatment option. As life sciences companies begin to address the significant unmet need in the rare disease space, clinical-stage companies developing treatments for rare diseases face a number of challenges as they aim to bring products to market, particularly when on the global scale.




Medigus and Golden Grand Expand Distribution Arrangement in China for $27M of MUSE Systems

Tue, 18 Jul 2017 07:00:00 EDT

OMER, ISRAEL--(Marketwired - Jul 18, 2017) - Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced that the Chinese exclusive distribution agreement with Golden Grand (Shanghai Golden Grand-Medical Instruments Ltd.) has been expanded to account for the increased interest in Medigus Ultrasonic Surgical Endostapler (MUSET) systems in China.




H-Source Announces Joint Promotion and Services Agreement With United Iroquois Shared Services, Inc.

Mon, 17 Jul 2017 17:30:00 EDT

VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 17, 2017) - H-Source Holdings Ltd. (TSX VENTURE:HSI)(OTCQB:HSCHF) (the "Company" or "H-Source") announces that it has entered into a joint promotion and services agreement with United Iroquois Shared Services, Inc., ("UISS"), the for-profit division of Iroquois Healthcare. UISS consists of over 500 members, including hospitals, surgery centers, nursing homes, physician groups, Health Maintenance Organizations (HMOs), and other health care providers. The H-Source platform will enable association members a direct cloud based marketplace to buy and sell surplus inventory and supplies with each other, further enabling members to collaborate to recover cost, reduce spend, and eliminate supply chain waste. Additionally, UISS members have access to the aggregate H-Source marketplace of member facilities. Michael Bevivino, UISS Director of Supply Chain Strategies, said, "I believe that this is truly a great service and I am glad that H-Source can help us bring it to our members. We look forward to working with H-Source Holdings Ltd."




UPDATE - Streetwise Reports Examines How One Multifaceted Biotech Company Began Trading on Canadian Securities Exchange

Mon, 17 Jul 2017 15:07:19 EDT

SAN FRANCISCO, CA--(Marketwired - July 17, 2017) - A Vancouver-based biotech firm that aims to become the first preventative medicine company commenced trading on the Canadian Securities Exchange July 14.




Advantis Corp. Ready for Ginos Roasters Product Launch

Mon, 17 Jul 2017 09:00:00 EDT

NEWPORT BEACH, CA--(Marketwired - Jul 17, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) is prepared for the upcoming launch of Gino's Roasters pre-rolled joints later this month.




Streetwise Reports Examines How One Multifaceted Biotech Company Began Trading on Canadian Securities Exchange

Mon, 17 Jul 2017 08:45:00 EDT

SAN FRANCISCO, CA--(Marketwired - July 17, 2017) - A Vancouver-based biotech firm that aims to become the first preventative medicine company commenced trading on the Canadian Securities Exchange July 14.




NEMUS Bioscience Announces NB2222 Pain and Anti-Addiction Data Accepted for Presentation at Upcoming Society of Neuroscience Meeting

Mon, 17 Jul 2017 08:30:00 EDT

COSTA MESA, CA--(Marketwired - Jul 17, 2017) - NEMUS Bioscience, Inc. (OTCQB: NMUS) announced that data recently obtained from the company's research and development partner, the University of Mississippi (UM), was accepted for presentation at the 2017 Annual Meeting of the Society of Neuroscience held in Washington, D.C. on November 11th-15th. The data being presented will show the superiority of the NEMUS proprietary analogue of CBD, NB2222, versus plant-derived CBD in ameliorating pain in a validated mouse (murine) model of chemotherapy-induced peripheral neuropathy using an opioid as an active comparator. Additional data will also be presented detailing the anti-addictive potential of NB2222 in an animal model of opioid addiction. The in vivo research was led by Professor Kenneth Sufka of the University of Mississippi based on the molecular cannabinoid discovery work performed by the team at ElSohly Laboratories, Inc. (ELI) in collaboration with the University, spearheaded by Dr. Mahmoud ElSohly, who also holds a faculty appointment at the University.




Smartphone Controlled Vision is Coming

Mon, 17 Jul 2017 08:05:00 EDT

EPGL Reveals "Omega" Contact Lens




Medovex Corporation Announces Pricing of $2.69 Million Concurrent Registered Direct Offering and Private Placement

Mon, 17 Jul 2017 08:00:00 EDT

ATLANTA, GA--(Marketwired - Jul 17, 2017) - Medovex Corp. (NASDAQ: MDVX), a developer of medical technology products, today announced that on Friday, July 14, 2017, it entered into definitive agreements with investors for the purchase and sale of 2,956,043 shares of common stock at a price of $.91 per share in a registered direct offering and warrants to purchase up to 1,478,022 shares of common stock at an exercise price of $1.15 per share in a concurrent private placement.




MTBC First Half 2017 Shareholder Update

Mon, 17 Jul 2017 07:30:00 EDT

SOMERSET, NJ--(Marketwired - Jul 17, 2017) - MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary, cloud-based healthcare IT solutions and services, issued a letter to shareholders today with an update on first half 2017 results.




How to Maximize Your Non-GLP Toxicology Studies: A Guide for Optimal Design and Methodology

Mon, 17 Jul 2017 07:30:00 EDT

In this new webinar hosted by Xtalks, the presenters will share both design and methodology guidance in Non-GLP Toxicology studies in translational models. The session will guide viewers in how to design the most optimal study to provide the greatest opportunity to generate robust, high-quality data, that gives maximum confidence to select new drug candidates and regulatory submissions.




mCig Broadens Construction Project Portfolio and Expands Cannabis Supply Division to the California Market

Mon, 17 Jul 2017 07:00:00 EDT

mCig Updates: Grow Contractors Projects, Supply Division Sales, and Expansion to California Markets




Zecotek China Appoints Business Development Director

Mon, 17 Jul 2017 03:15:00 EDT

SINGAPORE--(Marketwired - July 17, 2017) - Zecotek Photonics Inc. (TSX VENTURE: ZMS) (FRANKFURT: W1I) (OTC PINK: ZMSPF), a developer of leading-edge photonics technologies for healthcare, industrial and scientific markets, is pleased to announce that Mr. Thomas Lau has joined Zecotek China as Business Development Director. Mr. Lau is a native of China and brings more than 20 years of experience working in the photonics industry in China as a senior business development and operating executive. As Business Development Director he has been charged with managing an aggressive expansion strategy for Zecotek's patented photonics technologies within medical and non-medical industry sectors in China.




MedX Health Corp. Announces Further Closing of Brokered Private Placement

Fri, 14 Jul 2017 18:00:00 EDT

MISSISSAUGA, ON--(Marketwired - July 14, 2017) -

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES




Medifirst Solutions Answers Questions From Shareholders

Fri, 14 Jul 2017 13:10:51 EDT

FREEHOLD, NJ--(Marketwired - Jul 14, 2017) - MEDIFIRST SOLUTIONS, INC. (OTC PINK: MFST) (the "Company" or "Medifirst") would like to update shareholders in a Q&A format regarding the status of current sales and operations in connection with its FDA-cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device. The following questions were selected because they represent the most common questions asked.